Insider Selling: Dolby Laboratories (NYSE:DLB) CAO Sells $77,226.24 in Stock

Dolby Laboratories (NYSE:DLBGet Free Report) CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the transaction, the chief accounting officer directly owned 34,453 shares of the company’s stock, valued at $2,249,091.84. This trade represents a 3.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ryan Nicholson also recently made the following trade(s):

  • On Monday, August 10th, Ryan Nicholson sold 1,348 shares of Dolby Laboratories stock. The shares were sold at an average price of $62.04, for a total transaction of $83,629.92.
  • On Tuesday, August 4th, Ryan Nicholson sold 357 shares of Dolby Laboratories stock. The shares were sold at an average price of $60.63, for a total transaction of $21,644.91.

Dolby Laboratories Stock Down 3.8%

Shares of DLB traded down $2.48 during mid-day trading on Thursday, reaching $62.47. 1,641,422 shares of the company’s stock were exchanged, compared to its average volume of 929,635. The company has a market cap of $5.85 billion, a price-to-earnings ratio of 26.58 and a beta of 0.80. The company has a 50-day simple moving average of $55.49 and a two-hundred day simple moving average of $58.50. Dolby Laboratories has a 52-week low of $48.26 and a 52-week high of $73.78.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same quarter in the previous year, the business posted $0.78 EPS. The business’s quarterly revenue was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities research analysts predict that Dolby Laboratories will post 3.23 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio is currently 61.28%.

Dolby Laboratories announced that its Board of Directors has authorized a stock buyback program on Thursday, July 30th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to repurchase up to 7% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Fifth Third Bancorp lifted its holdings in Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the last quarter. Aquatic Capital Management LLC acquired a new position in shares of Dolby Laboratories in the 3rd quarter worth approximately $56,000. iSAM Funds UK Ltd acquired a new position in shares of Dolby Laboratories in the 3rd quarter worth approximately $68,000. Quarry LP raised its holdings in shares of Dolby Laboratories by 1,486.7% in the 4th quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock worth $76,000 after purchasing an additional 1,115 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in shares of Dolby Laboratories by 48.4% in the 4th quarter. Farther Finance Advisors LLC now owns 1,232 shares of the electronics maker’s stock worth $79,000 after purchasing an additional 402 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on DLB shares. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Weiss Ratings lowered shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, August 13th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, July 31st. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $83.00.

View Our Latest Research Report on Dolby Laboratories

Key Headlines Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

  • Positive Sentiment: Dolby is expanding beyond its traditional audio and video licensing markets into in-car gaming and live sports streaming. These initiatives could create additional licensing opportunities and support longer-term growth. Dolby Laboratories Expands Into In-Car Gaming and Live Sports Streaming
  • Neutral Sentiment: Dolby announced that longtime CEO Kevin Yeaman will retire after nearly two decades with the company. Marc Whitten, a former Microsoft and Amazon executive, will become president, CEO and a member of Dolby’s board following a long-term succession process. The orderly transition may limit disruption, while investors will look for evidence that the new CEO can accelerate growth. Dolby Laboratories Announces Leadership Transition
  • Neutral Sentiment: Zacks Research made several modest forecast adjustments. Estimates increased for fiscal 2027 first- and second-quarter EPS and third-quarter 2028 EPS, but the firm maintained a current-year consensus estimate of $3.23 per share. The mixed revisions suggest limited near-term earnings momentum rather than a major change in the outlook.
  • Negative Sentiment: Zacks lowered estimates for fiscal 2026 fourth-quarter EPS to $0.87 from $0.91, fiscal 2027 EPS to $3.19 from $3.22, fiscal 2027 fourth-quarter EPS to $0.82 from $0.87, and fiscal 2028 EPS to $3.38 from $3.40. These cuts could pressure the stock by reinforcing concerns about slower earnings growth.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.